Entera Bio Ltd. (ENTX)
NASDAQ: ENTX
· Real-Time Price · USD
1.99
0.02 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.00
0.50%
After-hours: Aug 15, 2025, 07:57 PM EDT
Entera Bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 223K | 181K | 4.58M | 4.54M | 4.48M | 4.48M | 14K | 22K | 66K | 134K | 285K | 417K | 482K | 571K | 627K | 537K | 480K |
Cost of Revenue | 214K | 185K | 116K | 88K | 55K | 2.25M | 2.25M | 2.24M | 2.26M | 101K | 280K | 339K | 369K | 388K | 306K | 272K | 240K |
Gross Profit | 9K | -4K | 4.46M | 4.45M | 4.43M | 2.23M | -2.23M | -2.22M | -2.19M | 33K | 5K | 78K | 113K | 183K | 321K | 265K | 240K |
Operating Income | -7.52M | -9.59M | -9.22M | -8.59M | -8.75M | -4.48M | -5.57M | -6.05M | -6.97M | -13.02M | -14.06M | -14.29M | -13.69M | -12.2M | -10.38M | -9.7M | -10.58M |
Interest Income | 20K | 65K | 65K | 101K | 86K | 63K | 63K | 27K | 22K | 44K | 44K | 44K | 44K | 29K | 29K | 29K | 29K |
Pretax Income | -4.94M | -9.53M | -9.18M | -8.51M | -8.69M | -8.86M | -9.75M | -10.26M | -11.13M | -12.73M | -5.1M | -4.66M | -6.59M | -5.11M | -12.07M | -11.28M | -9.36M |
Net Income | -4.96M | -9.54M | -9.18M | -8.54M | -8.72M | -4.47M | -5.69M | -5.97M | -6.83M | -12.84M | -4.72M | -4.51M | -6.48M | -5M | -12.16M | -11.32M | -9.36M |
Selling & General & Admin | 5.21M | 5.09M | 4.93M | 4.42M | 4.46M | 4.43M | 5.2M | 5.63M | 6.38M | 7.25M | 6.99M | 6.98M | 6.55M | 5.69M | 5.44M | 4.82M | 4.91M |
Research & Development | 4.89M | 4.49M | 4.27M | 4.17M | 4.29M | 4.5M | 4.86M | 4.9M | 5.09M | 5.85M | 7.12M | 7.44M | 7.3M | 6.74M | 5.29M | 5.16M | 5.92M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -13K | -31K | -37K | -37K | -36K | 5K | 11K | 11K | 23K | n/a | n/a | n/a |
Operating Expenses | 10.1M | 9.58M | 9.2M | 8.57M | 8.72M | 8.89M | 10M | 10.48M | 11.41M | 13.05M | 14.07M | 14.37M | 13.81M | 12.38M | 10.7M | 9.96M | 10.82M |
Interest Expense | n/a | n/a | 32K | 32K | 32K | 32K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.31M | 9.77M | 9.32M | 8.64M | 8.75M | 8.9M | 10.01M | 10.5M | 11.46M | 13.15M | 14.35M | 14.71M | 14.18M | 12.77M | 11M | 10.24M | 11.06M |
Income Tax Expense | -6.03M | -6.03M | -6.04M | 29K | 29K | -4.39M | -4.07M | -4.29M | -4.29M | 115K | -387K | -148K | -104K | -111K | 141K | 109K | 98K |
Shares Outstanding (Basic) | 43.38M | 37.65M | 37.64M | 37.09M | 36.74M | 29.7M | 28.81M | 28.81M | 28.81M | 28.81M | 28.81M | 28.81M | 28.8M | 28.68M | 28.68M | 24.72M | 21.89M |
Shares Outstanding (Diluted) | 43.38M | 37.65M | 37.64M | 37.09M | 36.74M | 29.7M | 28.81M | 28.81M | 28.81M | 28.81M | 28.81M | 28.81M | 28.8M | 28.68M | 28.68M | 24.72M | 21.89M |
EPS (Basic) | 0.02 | -0.1 | -0.1 | -0.26 | -0.29 | -0.15 | -0.2 | -0.21 | -0.24 | -0.44 | 0.69 | 0.69 | 0.59 | 0.62 | -0.52 | -0.52 | -0.48 |
EPS (Diluted) | 0.02 | -0.1 | -0.1 | -0.26 | -0.29 | -0.15 | -0.2 | -0.21 | -0.24 | -0.44 | 0.69 | 0.69 | 0.59 | 0.62 | -0.52 | -0.52 | -0.48 |
EBITDA | -7.49M | -9.54M | -9.16M | -8.53M | -8.69M | -8.84M | -9.94M | -10.41M | -11.36M | -12.98M | -5.2M | -5.55M | -4.84M | -3.36M | -10.2M | -9.36M | -10.28M |
EBIT | -7.52M | -9.59M | -9.21M | -8.58M | -8.74M | -8.89M | -10M | -10.47M | -11.39M | -13.02M | -14.06M | -14.42M | -13.74M | -12.24M | -10.42M | -9.62M | -10.58M |
Depreciation & Amortization | 33K | 46K | 48K | 51K | 55K | 56K | 59K | 61K | 62K | 64K | -81K | -65K | -22K | 53K | 255K | 274K | 266K |